Lawrence Karsh, MD, FACS
No bio available.
Financial relationships
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Oncology)Ineligible company:FKDMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:Spouse or PartnerType of financial relationship:Consultant or Advisor (General Urology)Ineligible company:Swan Valley Medical
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Oncology)Ineligible company:VaxiionMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Investment Interest (Oncology)Ineligible company:3D BiopsyMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Oncology)Ineligible company:NymoxMitigation strategy:DivestDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:Precision BiopsyMitigation strategy:DivestDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:OPKOMitigation strategy:DivestDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Oncology)Ineligible company:Precision MedMitigation strategy:DivestDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Oncology)Ineligible company:AugmenixMitigation strategy:DivestDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:Myriad GeneticsMitigation strategy:DivestDate reviewed:09/20/2022